MRVI vs. ARES
MRVI (Maravai LifeSciences Holdings, Inc.) and ARES (Ares Management Corporation) are both stocks. MRVI operates in Biotechnology (Healthcare), while ARES operates in Asset Management (Financial Services). Over the past 5 years, MRVI returned -35.31%/yr vs 20.60%/yr for ARES. At a 0.25 correlation, their price movements are largely independent.
Performance
MRVI vs. ARES - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MRVI achieves a 48.92% return, which is significantly higher than ARES's -22.80% return.
MRVI
- 1D
- 0.21%
- 1M
- 27.70%
- YTD
- 48.92%
- 6M
- 37.89%
- 1Y
- 118.02%
- 3Y*
- -28.66%
- 5Y*
- -35.31%
- 10Y*
- —
ARES
- 1D
- -4.04%
- 1M
- 2.60%
- YTD
- -22.80%
- 6M
- -22.12%
- 1Y
- -24.14%
- 3Y*
- 14.81%
- 5Y*
- 20.60%
- 10Y*
- 29.23%
MRVI vs. ARES - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
MRVI Maravai LifeSciences Holdings, Inc. | 48.92% | -40.37% | -16.79% | -54.23% | -65.85% | 49.38% | -6.03% |
ARES Ares Management Corporation | -22.80% | -5.72% | 52.68% | 79.52% | -12.75% | 77.75% | 5.51% |
Correlation
The correlation between MRVI and ARES is 0.28, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.28 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.17 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.26 |
Correlation (All Time) Calculated using the full available price history since Nov 23, 2020 | 0.25 |
The correlation between MRVI and ARES shifts across timeframes, from 0.17 (3 years) to 0.28 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
MRVI:
-$0.72
ARES:
$2.83
MRVI:
3.43
ARES:
4.29
MRVI:
$204.73M
ARES:
$6.31B
MRVI:
$59.37M
ARES:
$4.46B
MRVI:
-$118.27M
ARES:
$2.42B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MRVI vs. ARES — Risk / Return Rank
MRVI
ARES
MRVI vs. ARES - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Maravai LifeSciences Holdings, Inc. (MRVI) and Ares Management Corporation (ARES). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| MRVI | ARES | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.23 | ||
| Sortino ratioReturn per unit of downside risk | +3.20 | ||
| Omega ratioGain probability vs. loss probability | 1.29 | 0.92 | +0.38 |
| Calmar ratioReturn relative to maximum drawdown | 3.97 | -0.49 | +4.46 |
| Martin ratioReturn relative to average drawdown | 8.88 | -0.99 | +9.87 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| MRVI | ARES | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.63 | -0.60 | +2.23 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.47 | 0.56 | -1.03 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.80 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.38 | 0.62 | -1.01 |
Drawdowns
MRVI vs. ARES - Drawdown Comparison
The maximum MRVI drawdown since its inception was -97.16%, which is greater than ARES's maximum drawdown of -49.73%. Use the drawdown chart below to compare losses from any high point for MRVI and ARES.
Loading charts...
Drawdown Indicators
| MRVI | ARES | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.16% | -49.73% | -47.43% |
Max Drawdown (1Y)Largest decline over 1 year | -29.93% | -49.05% | +19.12% |
Max Drawdown (3Y)Largest decline over 3 years | -88.25% | -49.73% | -38.52% |
Max Drawdown (5Y)Largest decline over 5 years | -97.16% | -49.73% | -47.43% |
Max Drawdown (10Y)Largest decline over 10 years | — | -49.73% | — |
Current DrawdownCurrent decline from peak | -92.02% | -35.00% | -57.02% |
Average DrawdownAverage peak-to-trough decline | -67.60% | -11.28% | -56.32% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.34% | 24.48% | -11.14% |
Volatility
MRVI vs. ARES - Volatility Comparison
Maravai LifeSciences Holdings, Inc. (MRVI) has a higher volatility of 24.44% compared to Ares Management Corporation (ARES) at 9.18%. This indicates that MRVI's price experiences larger fluctuations and is considered to be riskier than ARES based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MRVI | ARES | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 24.44% | 9.18% | +15.26% |
Volatility (6M)Calculated over the trailing 6-month period | 43.54% | 34.82% | +8.72% |
Volatility (1Y)Calculated over the trailing 1-year period | 72.75% | 40.54% | +32.21% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 74.72% | 37.22% | +37.50% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 73.52% | 36.63% | +36.89% |
Dividends
MRVI vs. ARES - Dividend Comparison
MRVI has not paid dividends to shareholders, while ARES's dividend yield for the trailing twelve months is around 4.51%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ARES Ares Management Corporation | 4.51% | 3.29% | 2.10% | 2.59% | 3.57% | 2.31% | 3.40% | 3.59% | 7.50% | 5.65% | 4.32% | 6.81% |
MRVI Maravai LifeSciences Holdings, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
MRVI vs. ARES - Financials Comparison
This section allows you to compare key financial metrics between Maravai LifeSciences Holdings, Inc. and Ares Management Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
MRVI vs. ARES - Profitability Comparison
MRVI - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Maravai LifeSciences Holdings, Inc. reported a gross profit of 33.70M and revenue of 65.84M. Therefore, the gross margin over that period was 51.2%.
ARES - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Ares Management Corporation reported a gross profit of 1.47B and revenue of 1.53B. Therefore, the gross margin over that period was 96.1%.
MRVI - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Maravai LifeSciences Holdings, Inc. reported an operating income of 720.00K and revenue of 65.84M, resulting in an operating margin of 1.1%.
ARES - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Ares Management Corporation reported an operating income of 364.95M and revenue of 1.53B, resulting in an operating margin of 23.8%.
MRVI - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Maravai LifeSciences Holdings, Inc. reported a net income of -3.73M and revenue of 65.84M, resulting in a net margin of -5.7%.
ARES - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Ares Management Corporation reported a net income of 142.59M and revenue of 1.53B, resulting in a net margin of 9.3%.
Frequently Asked Questions
MRVI and ARES have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
MRVI has higher volatility (24.44%) compared to ARES (9.18%). In terms of maximum drawdown, MRVI dropped -97.16% vs ARES's -49.73%.
MRVI currently has the higher Sharpe Ratio (1.63 vs -0.60), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MRVI and ARES
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer